Novavax Inc (NVAX) stock
NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.96+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.31BP/E –Yield –
Novavax market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Novavax's market cap was $1.64B on Nov 11, 2026, against $1.15B a year earlier. Over the last 5 years it ranged from $474.92M to $10.79B, with a median of $1.34B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.64B | +50.7% |
| 2025 | Dec 31, 2025 | $1.09B | -15.2% |
| 2024 | Dec 31, 2024 | $1.29B | +125.9% |
| 2023 | Dec 29, 2023 | $569.91M | -29.4% |
| 2022 | Dec 30, 2022 | $806.74M | -92.5% |
| 2021 | Dec 31, 2021 | $10.79B | +53.8% |
| 2020 | Dec 31, 2020 | $7.02B | +6806.3% |
| 2019 | Dec 31, 2019 | $101.60M | -85.6% |
| 2018 | Dec 31, 2018 | $704.22M | +83.1% |
| 2017 | Dec 29, 2017 | $384.62M | +12.5% |
| 2016 | Dec 30, 2016 | $341.76M | -84.9% |
| 2015 | Dec 31, 2015 | $2.26B | +60.1% |
| 2014 | Dec 31, 2014 | $1.41B | +32.5% |
| 2013 | Dec 31, 2013 | $1.07B | +327.4% |
| 2012 | Dec 31, 2012 | $249.77M | +72.5% |
| 2011 | Dec 30, 2011 | $144.81M | – |
See a number that looks wrong?